A
Anthony P. Moll
Researcher at Yale University
Publications - 60
Citations - 4393
Anthony P. Moll is an academic researcher from Yale University. The author has contributed to research in topics: Tuberculosis & Extensively drug-resistant tuberculosis. The author has an hindex of 26, co-authored 57 publications receiving 4107 citations.
Papers
More filters
Journal ArticleDOI
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
Neel R. Gandhi,Neel R. Gandhi,Anthony P. Moll,A. Willem Sturm,Robert Pawinski,Thiloshini Govender,Umesh G. Lalloo,Kimberly Zeller,Kimberly Zeller,Jason R. Andrews,Gerald Friedland +10 more
TL;DR: MDR tuberculosis is more prevalent than previously realised in a rural area in KwaZulu Natal, South Africa and has been transmitted to HIV co-infected patients and is associated with high mortality.
Journal ArticleDOI
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
Evan W. Orenstein,Sanjay Basu,N. Sarita Shah,Jason R. Andrews,Gerald Friedland,Anthony P. Moll,Neel R. Gandhi,Alison P. Galvani +7 more
TL;DR: In this paper, the authors used a Bayesian random-effects meta-analysis of the available therapeutic studies to assess how the reported proportion of patients treated successfully is influenced by differences in treatment regimen design, study methodology, and patient population.
Journal ArticleDOI
HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.
Neel R. Gandhi,N. Sarita Shah,Jason R. Andrews,Venanzio Vella,Anthony P. Moll,Michelle Scott,Darren Weissman,Claudio Marra,Umesh G. Lalloo,Gerald Friedland +9 more
TL;DR: Mortality from MDR and XDR TB in this high HIV-prevalence region is extraordinarily high, particularly within the first 30 days, and efforts to reduce mortality must focus on earlier diagnosis and early initiation of second-line TB and antiretroviral therapy.
Journal ArticleDOI
Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study
Sanjay Basu,Jason R. Andrews,Eric M. Poolman,Neel R. Gandhi,N. Sarita Shah,Anthony P. Moll,Prashini Moodley,Alison P. Galvani,Gerald Friedland +8 more
TL;DR: A synergistic combination of available nosocomial infection control strategies could prevent nearly half of XDR tuberculosis cases, even in a resource-limited setting.
Journal ArticleDOI
Exogenous Reinfection as a Cause of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Rural South Africa
Jason R. Andrews,Neel R. Gandhi,Prashini Moodley,N. Sarita Shah,Louise Bohlken,Anthony P. Moll,Manormoney Pillay,Gerald Friedland,A. Willem Sturm +8 more
TL;DR: Exogenous reinfection is an important mechanism for the development of MDR and XDR TB in areas of South Africa with a high prevalence of TB and human immunodeficiency virus (HIV) infection.